Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
Top Sells
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$1.02B |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$401M |
| 3 |
iShares MSCI Brazil ETF
EWZ
|
+$184M |
| 4 |
iShares China Large-Cap ETF
FXI
|
+$184M |
| 5 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$169M |
Sector Composition
| 1 | Consumer Discretionary | 6.7% |
| 2 | Communication Services | 6.35% |
| 3 | Technology | 5.26% |
| 4 | Industrials | 4.02% |
| 5 | Healthcare | 3.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NBSE
3051
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
| $121K | ﹤0.01% |
+850
| New | +$121K |
|
|
BBBY
3052
Bed Bath & Beyond, Inc.
BBBY
$563M
| $120K | ﹤0.01% |
26,544
-66,581
| -71% | -$301K |
|
3053
InfuSystem Holdings
INFU
$205M
| $120K | ﹤0.01% |
+14,122
| New | +$120K |
|
|
EHI
3054
Western Asset Global High Income Fund
EHI
$202M
| $119K | ﹤0.01% |
+15,926
| New | +$119K |
|
3055
Hercules Capital
HTGC
$3.5B
| $119K | ﹤0.01% |
+15,550
| New | +$119K |
|
|
GSB
3056
DELISTED
GlobalSCAPE, Inc.
GSB
| $119K | ﹤0.01% |
+16,772
| New | +$119K |
|
3057
Akebia Therapeutics
AKBA
$769M
| $118K | ﹤0.01% |
15,523
+4,280
| +38% | +$32.5K |
|
3058
Ocular Therapeutix
OCUL
$2.2B
| $118K | ﹤0.01% |
+23,779
| New | +$118K |
|
|
AVYA
3059
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
| $118K | ﹤0.01% |
14,560
-59,917
| -80% | -$486K |
|
|
APHA
3060
DELISTED
Aphria Inc. Common Shares
APHA
| $118K | ﹤0.01% |
38,710
+10,738
| +38% | +$32.7K |
|
3061
Fortress Biotech
FBIO
$105M
| $117K | ﹤0.01% |
+4,123
| New | +$117K |
|
3062
Hanmi Financial
HAFC
$766M
| $116K | ﹤0.01% |
+10,708
| New | +$116K |
|
3063
Liberty All-Star Equity Fund
USA
$1.92B
| $116K | ﹤0.01% |
23,955
+8,907
| +59% | +$43.1K |
|
|
MDRX
3064
DELISTED
Veradigm Inc. Common Stock
MDRX
| $116K | ﹤0.01% |
16,493
-29,200
| -64% | -$205K |
|
3065
Dyadic International
DYAI
$36.2M
| $115K | ﹤0.01% |
+22,124
| New | +$115K |
|
3066
Inovio Pharmaceuticals
INO
$123M
| $115K | ﹤0.01% |
+1,290
| New | +$115K |
|
3067
MediciNova
MNOV
$61.3M
| $115K | ﹤0.01% |
30,800
+5,700
| +23% | +$21.3K |
|
|
VSTO
3068
DELISTED
Vista Outdoor Inc.
VSTO
| $115K | ﹤0.01% |
13,083
-10,643
| -45% | -$93.6K |
|
3069
Adient
ADNT
$2.06B
| $114K | ﹤0.01% |
12,577
-421,385
| -97% | -$3.82M |
|
|
MFA
3070
MFA Financial
MFA
$1,000M
| $114K | ﹤0.01% |
+18,363
| New | +$114K |
|
3071
Teucrium Sugar Fund
CANE
$12.2M
| $113K | ﹤0.01% |
20,746
-21,751
| -51% | -$118K |
|
3072
MBIA
MBI
$367M
| $112K | ﹤0.01% |
+15,654
| New | +$112K |
|
|
RPAI
3073
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
| $112K | ﹤0.01% |
+21,739
| New | +$112K |
|
3074
Designer Brands
DBI
$214M
| $111K | ﹤0.01% |
22,303
-66,539
| -75% | -$331K |
|
3075
SunCoke Energy
SXC
$677M
| $111K | ﹤0.01% |
+28,924
| New | +$111K |
|